Local institution

Bathurst, New Brunswick E2A 4X7

0 studies enrolling now · 12 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, Depression, Diabetes Mellitus, Type 2, Dyslipidemia, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes — Completed
• Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes — Completed
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone — Completed
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise — Completed
• Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression — Completed
• Safety Study of BMS-823778 in Subjects With Type 2 Diabetes — Completed
• Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin — Completed
• Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone — Completed
• Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• Safety Study of BMS-770767 in Subjects With Hypercholesterolemia — Completed